Site Search

Light Protection Tests - Mayo Clinic Laboratories

Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...

International - Mayo Clinic Laboratories

Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...

MGLE - Overview: Myasthenia Gravis/Lambert-Eaton Myasthenic Syndrome Evaluation, Serum

Confirming the autoimmune basis of a defect in neuromuscular transmission (eg, myasthenia gravis [MG], Lambert-Eaton myasthenic syndrome [LEMS]) Distinguishing LEMS from autoimmune forms of MG Providing a quantitative autoantibody...

MGMR - Overview: Myasthenia Gravis Evaluation with Muscle-Specific Kinase (MuSK) Reflex, Serum

Diagnosing autoimmune myasthenia gravis (MG) in adults and children Distinguishing autoimmune from congenital MG in adults and children or other acquired forms of neuromuscular junction transmission disorders Establishing a quantitative...

search - Mayo Clinic Laboratories

Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...

Clinical Application of Next-Generation Sequencing (NGS) Testing - Insights

October 8, 2017 | Rochester, Minnesota This symposium is designed for any provider who treats patients with hematologic malignancies (e.g., oncologists, hematologists, and physician assistants), pathologists, hematopathologists,...

A Test in Focus Archives - Page 3 of 11 - Insights

Skip to Content MayoACCESS MayoLINK Register My Dashboard...

A Test in Focus Archives - Insights

Skip to Content MayoACCESS MayoLINK Register My Dashboard...

A Test in Focus Archives - Page 11 of 11 - Insights

Skip to Content MayoACCESS MayoLINK Register My Dashboard...

A Test in Focus Archives - Page 4 of 11 - Insights

Skip to Content MayoACCESS MayoLINK Register My Dashboard...

AHUSD - Overview: Atypical Hemolytic Uremic Syndrome Complement Panel, Serum and Plasma

Detecting deficiencies in the alternative pathway that can cause atypical-hemolytic uremic syndrome, dense deposit disease, and C3 glomerulonephritis A second-tier test that aids in the differential diagnosis of thrombotic...

search - Mayo Clinic Laboratories

Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...

search - Mayo Clinic Laboratories

Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...

MCL - TCR V Beta Spectratyping Assay Patient Information - MC1235-204

MCL - TCR V Beta Spectratyping Assay Patient Information

search - Mayo Clinic Laboratories

Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...

#ASH18 Live Blog - Insights

Our Mayo Clinic colleagues are in San Diego for the 60th American Society of Hematology Annual Meeting and Exhibition. Follow this blog for live updates from #ASH18 as we attend the conference, mingle with colleagues at booth #2927, and...

Ordering & Results - Mayo Clinic Laboratories

Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...

The Metals Laboratory Tests Beethoven's Hair: Paul Jannetto, Ph.D. - Insights

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Paul Jannetto, Ph.D., director of the Metals Laboratory at Mayo Clinic, and Sarah Erdahl,...

Test Classification Updates - Mayo Clinic Laboratories

Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...

MCL - Tissue Requirements for Solid Tumor Next-Generation Sequencing - MC2775-468

MCL - Tissue Requirements for Solid Tumor Next-Generation Sequencing

postmortem_screening_algorithm.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 07/2025 No risk factors present Contact Biochemical Genetics Laboratory 800-533-1710 ■ Order PMSBB / Postmortem Screening, Bile and Blood Spots ■ Collect...

newborn-screen-decreased-free-carnitineco.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 07/2025 Newborn screen result: ■ Decreased free carnitine (C0) Perform: Plasma ammonia, blood gas, glucose, electrolytes, creatine kinase, liver function...

LabLicense

Laboratory Identification Number: 29685A Name and Director of Laboratory: MAYO CLINIC LABS-ROCH SUPERIOR DR NIKOLA A BAUMANN, PH.D. 3050 SUPERIOR DRIVE NW ROCHESTER, MN 55901 Owner: MAYO CLINIC ISSUE DATE: August 15,...

LabLicense

Laboratory Identification Number: 09003A Name and Director of Laboratory: MAYO CLINIC LABS-ROCHESTER MAIN CAMPUS NIKOLA A BAUMANN, PH.D. 200 FIRST STREET SW HILTON 530 ROCHESTER, MN 55905 Owner: MAYO CLINIC ISSUE DATE:...

search - Mayo Clinic Laboratories

Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...

Unique Test Screens for Recently Identified Peripheral Neuropathy: Matthew Schultz, Ph.D., and Amy White, M.S., CGC - Insights

Matthew J. Schultz, Ph.D., and Amy L. White, M.S., CGC, explain how Mayo Clinic Laboratories' unique urine assay (Mayo ID: SORD) screens for peripheral neuropathy arising from SORD gene variants. Although recently identified, SORD-related...

Krabbe disease added to federal newborn screening panel - Insights

Thanks to advocacy work by a group of medical experts, including some from Mayo Clinic, the U.S. Department of Health and Human Services now recommends all states screen for infantile Krabbe disease to help save newborn lives.

Custom gene ordering - Insights

With Mayo Clinic Laboratories’ custom gene ordering tool, clients can create specific gene panels to meet their patient’s individual needs.

Inborn errors of metabolism - Insights

Learn more about how Mayo Clinic Laboratories’ comprehensive menu of biochemical and molecular testing can diagnose inborn errors of metabolism.

Making Informed Decisions About Genetic Testing: Carrie Lahner, M.S., CGC, and April Studinski Jones, M.S., CGC - Insights

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by genetic counselors Carrie Lahner, M.S., CGC, and April Studinski Jones, M.S., CGC, to discuss how...

Hereditary testing by specialty - Insights

Mayo Clinic Laboratories is a one-stop laboratory for hereditary testing, featuring a robust menu of molecular, cytogenic, biochemical, and functional assays that support diagnosis and care.

Whole exome sequencing for hereditary disorders - Insights

Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC, discuss whole exome sequencing (WES) at Mayo Clinic Laboratories. The comprehensive evaluation uses next-generation sequencing to detect for single nucleotide variants, small...

Advancing Immunosuppressive Therapy in Solid Organ Transplantation: Integrating Pharmacogenomics, Therapeutic Drug Monitoring, and Precision Medicine - Insights

Register now: Aug. 13, 2025 - PACE/State of FL - The critical role of pharmacogenomics and therapeutic drug monitoring (TDM) in managing immunosuppressive therapy for solid organ transplant recipients.

Regaining quality of life after a decade lost to misdiagnosis: Kelly Dubois - Insights

Misdiagnosed with acromegaly, a disease marked by too much growth hormone, and plagued by a host of mysterious health problems from unnecessary medications, Kelly DuBois finally found answers after pharmacogenomic testing from Mayo Clinic...

Pharmacogenomics - Insights

Including comprehensive panels and medication targeted assays, Mayo Clinic Laboratories pharmacogenomic testing focuses on clinically actionable genes and enables the detection of more alleles than other testing.

Unique testing helps identify cause of sudden cardiac death: Linnea Baudhuin, Ph.D., and Kate Kotzer, M.S., CGC - Insights

Linnea Baudhuin, Ph.D., and Kate Kotzer, M.S., CGC, describe how Mayo Clinic Laboratories' postmortem genetic tests can provide answers after a sudden unexplained cardiac death. Test results are important for managing family members' risk...

Prenatal - Insights

Including carrier screening, molecular testing, and cytogenetic analysis, Mayo Clinic Laboratories prenatal evaluations provide vital insights for prospective and expecting parents.

Familial studies - Insights

At Mayo Clinic Laboratories, familial variant analysis can clarify genetic variants in family members when a variant of interest has been previously identified.

Genetic Tests Identify Risk of Fluoropyrimidine-Induced Toxicity: Ann Moyer, M.D., Ph.D. - Insights

Ann Moyer, M.D., Ph.D., explains how Mayo Clinic Laboratories' unique genetic tests identify patients at high risk of severe reactions to fluoropyrimidines — a type of chemotherapy drug. Test results can guide clinical decision-making for...

Genetic counselors - Insights

Mayo Clinic Laboratories’ genetic counselors are experts on heritable illness who provide a wealth of knowledge to guide appropriate testing utilization and interpret results.

Oncology - Insights

Offering more than 150 oncology-specific tests in nine subspecialty areas, Mayo Clinic Laboratories’ cancer tests are developed by an experienced team of board-certified geneticists, genetic counselors, and physicians.

MayoComplete next-generation sequencing: Transforming comprehensive cancer care - Insights

Offering increased sensitivity and improved accuracy, MayoComplete next-generation testing ensures health care providers understand the distinctive genetic features of their patients’ cancer to make informed decisions to guide their care.

Hereditary - Insights

Find out how our hereditary cancer panels use next-generation sequencing to evaluate dozens of genes associated with cancer risk.

Reclaiming strength and independence after rare cancer diagnosis: Alexa Lofaro - Insights

It’s been more than three years since a team of specialists and genetic testing by Mayo Clinic Laboratories helped pinpoint the cause of Alexa Lofaro’s failing health. And today, she says she continues to feel “so much better” than she did...

Sarcoma Testing - Mayo Clinic Laboratories

Supplementing the histologic diagnosis with genetic testing can improve diagnostic accuracy and overall patient management.

Lung Cancer Testing - Mayo Clinic Laboratories

Mayo Clinic Laboratories innovates at the speed of medical advancement, and offers comprehensive options for diagnostic, prognostic, and predictive lung cancer testing.

Pediatrics - Insights

Find out how our pediatric oncology testing was designed to deliver individualized insights to confirm diagnosis and guide treatment.

Roles, Goals, and Communication: Launching an Outreach Program - Insights

In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, is joined by colleagues Ellen Dijkman Dulkes and Brianne Newton to discuss building an...

Overcoming Common Barriers to Outreach Success - Insights

In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, is joined by colleagues Ellen Dijkman Dulkes and Brianne Newton. They discuss common...

Reserve your spot at Leveraging the Laboratory 2025 - Insights

Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.